ProfileGDS4718 / 208498_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 64% 73% 59% 68% 47% 59% 60% 64% 63% 63% 78% 55% 49% 49% 61% 61% 44% 53% 57% 50% 57% 58% 63% 61% 65% 68% 71% 81% 56% 35% 64% 71% 61% 45% 42% 62% 66% 70% 71% 62% 64% 67% 29% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5678866
GSM549102patient 115, normal, homogenized [OPG study]6.378664
GSM549104patient 119, normal, homogenized [OPG study]7.2385673
GSM549108patient 138, normal, homogenized [OPG study]6.1042559
GSM549119patient 077, normal, homogenized [OPG study]6.6496968
GSM549133patient 032, cancer, homogenized [OPG study]5.2687847
GSM549139patient 042, cancer, homogenized [OPG study]6.0748859
GSM549099patient 107, normal, homogenized [OPG study]6.0987560
GSM549109patient 139, normal, homogenized [OPG study]6.3748764
GSM549110patient 046, normal, homogenized [OPG study]6.326363
GSM549114patient 063, normal, homogenized [OPG study]6.3288863
GSM549122patient 082, normal, homogenized [OPG study]7.6045378
GSM549134patient 033, cancer, homogenized [OPG study]5.7632355
GSM549136patient 036, cancer, homogenized [OPG study]5.4215849
GSM549140patient 044, cancer, homogenized [OPG study]5.4070249
GSM549111patient 047, normal, homogenized [OPG study]6.1914661
GSM549113patient 057, normal, homogenized [OPG study]6.1340461
GSM549132patient 031, cancer, homogenized [OPG study]5.1782644
GSM549137patient 038, cancer, homogenized [OPG study]5.6577853
GSM549142patient 047, cancer, homogenized [OPG study]6.0408757
GSM549100patient 110, normal, homogenized [OPG study]5.5090250
GSM549107patient 135, normal, homogenized [OPG study]5.9312557
GSM549115patient 068, normal, homogenized [OPG study]5.9684458
GSM549116patient 072, normal, homogenized [OPG study]6.3724963
GSM549120patient 078, normal, homogenized [OPG study]6.1852661
GSM549131patient 030, cancer, homogenized [OPG study]6.4732365
GSM549118patient 074, normal, homogenized [OPG study]6.6899168
GSM549129patient 027, cancer, homogenized [OPG study]6.9821571
GSM549123patient 088, normal, homogenized [OPG study]7.9671481
GSM549124patient 006, cancer, homogenized [OPG study]5.8703456
GSM549126patient 015, cancer, homogenized [OPG study]4.7573735
GSM549128patient 025, cancer, homogenized [OPG study]6.4196464
GSM549103patient 117, normal, homogenized [OPG study]6.9091571
GSM549117patient 073, normal, homogenized [OPG study]6.1211761
GSM549138patient 041, cancer, homogenized [OPG study]5.235245
GSM549141patient 045, cancer, homogenized [OPG study]5.0312142
GSM549130patient 028, cancer, homogenized [OPG study]6.2503462
GSM549101patient 111, normal, homogenized [OPG study]6.5740966
GSM549105patient 128, normal, homogenized [OPG study]6.8742270
GSM549106patient 134, normal, homogenized [OPG study]7.0813971
GSM549112patient 048, normal, homogenized [OPG study]6.276762
GSM549125patient 011, cancer, homogenized [OPG study]6.4243264
GSM549127patient 024, cancer, homogenized [OPG study]6.7187967
GSM549135patient 035, cancer, homogenized [OPG study]4.4635829